Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire : 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study

DSpace/Manakin Repository

 
 
See more statistics about this item